等待开盘 12-15 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Benchmark analyst Michael Albanses maintains Holley (NYSE:HLLY) with a Buy and raises the price target from $4 to $4.5.
11-10 23:19
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 10:22
Holley shares are trading higher after the company reported better-than-expecte...
11-07 21:53
Holley (NYSE:HLLY) raises FY2025 sales outlook from $580.000 million-$595.000 million to $590.000 million-$605.000 million vs $591.534 million estimate.
11-07 20:34
Holley (NYSE:HLLY) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.05 by 34.78 percent. This is a 400 percent increase over losses of $(0.01) per share from the same
11-07 20:31
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
Holley (NYSE:HLLY) is set to give its latest quarterly earnings report on Frida...
11-07 00:04
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20